Details of the Drug-Related molecule(s) Interaction Atlas

BDBM50173327 Drug Info

CHEMBL3808499; SCHEMBL17525395; BDBM50173327

Cross-matching ID

PubChem CID

118888913

TTD Drug ID

DMKEVDL

General Information of Drug (ID: DMKEVDL)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting G protein-coupled receptor kinase 5 (GRK5)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
BDBM50173323	DM7RTQP	N. A.	N. A.	Patented	[1]
BDBM50173330	DM1PU37	N. A.	N. A.	Patented	[1]
PMID24210504C1o	DM4LEUT	Discovery agent	N.A.	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
G protein-coupled receptor kinase 5 (GRK5)	TTTCXO0	GRK5_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	G protein-coupled receptor kinase 2 inhibitors and methods for use of the same. US10023564.
2	Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors. Bioorg Med Chem Lett. 2013 Dec 15;23(24):6711-6.